By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – eBioscience and Australian firm Anteo Diagnostics today announced a licensing deal covering Anteo's Mix&Go technology.

Anteo will supply eBioscience with its Mix&Go product for the manufacture of reagents. In return it will receive an initial upfront payment from eBioscience, fixed revenues for Mix&Go reagents supplied, and royalties on the sale of products by eBioscience using Mix&Go.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.